1 paper mentions it4 findings
See all 1 papers on KDM biological age, PhenoAge and homeostatic dysregulation
“Advanced BA quantified by clinical biomarkers is associated with increased risks of any cancer, lung cancer, and colorectal cancer.”
Associations
4Prostate cancer incidence
downin humans1
1 study
Prostate cancer incidence
downin humans1
KDM biological age, PhenoAge and homeostatic dysregulation is associated with prostate cancer incidence in humans.
“Furthermore, we observed an inverse association between BA measures and prostate cancer”
HumansAssociation attenuated after removing glycated hemoglobin and serum glucose from the biological age algorithmsMedian follow-up of 10.9 years
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
British journal of cancer
Colorectal cancer incidence
upin humans1
1 study
Colorectal cancer incidence
upin humans1
KDM biological age, PhenoAge and homeostatic dysregulation is associated with colorectal cancer incidence in humans (No history of cancer at enrolment).
“All BA measures were also associated with increased risks of lung and colorectal cancers, but only PhenoAge was associated with breast cancer risk.”
HumansNo history of cancer at enrolmentMedian follow-up of 10.9 yearsn = 308,156
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
British journal of cancer
Lung cancer incidence
upin humans1
1 study
Lung cancer incidence
upin humans1
KDM biological age, PhenoAge and homeostatic dysregulation is associated with lung cancer incidence in humans (No history of cancer at enrolment).
“All BA measures were also associated with increased risks of lung and colorectal cancers, but only PhenoAge was associated with breast cancer risk.”
HumansNo history of cancer at enrolmentMedian follow-up of 10.9 yearsn = 308,156
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
British journal of cancer
Cancer incidence
upin humans1HR 1.04
1 study
Cancer incidence
upin humans1HR 1.04
KDM biological age, PhenoAge and homeostatic dysregulation is associated with cancer incidence in humans (No history of cancer at enrolment; adjusted for common cancer risk factors) (Per SD: age-adjusted KDM HR 1.04 (95% CI 1.03–1.05); age-adjusted PhenoAge HR 1.09 (1.07–1.10); HD HR 1.02 (1.01–1.03)).
“Advanced BA quantified by clinical biomarkers is associated with increased risks of any cancer, lung cancer, and colorectal cancer.”
HumansNo history of cancer at enrolment; adjusted for common cancer risk factors1-standard deviation incrementMedian follow-up of 10.9 yearsn = 308,156
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
British journal of cancer